Equity turns negative as loan book runs off and RTO shell emerges

What changed

Revenue (interest and fee income) fell 63.7% to NZ$33.8m from NZ$92.9m. The net loss narrowed 36.9% to NZ$215.7m from NZ$341.7m, with PBT and NPAT identical in both periods because no tax was recognised. Operating cash flow remained positive at NZ$331.3m but was down 27.4% year on year. The balance sheet contracted sharply: total assets fell 52.8% to NZ$1.5b, gross borrowings fell 43.2% to NZ$1.4b, cash fell 93.3% to NZ$152.4m, and total equity flipped from NZ$348.5m to negative NZ$76.6m. The release flags that capital raised will fund working capital ahead of a proposed reverse takeover transaction.

What matters

• Balance sheet has broken, not just weakened. Equity is now negative NZ$76.6m, and net debt has risen to NZ$1.3b from NZ$106.7m a year earlier despite gross borrowings falling, because the cash buffer has been almost entirely consumed. This is the central read on the period.
• The business is being wound down, not run. Prior-period commentary referenced deploying funds into new loan receivables; current commentary is about an RTO shell and acquisition targets. The 63.7% revenue decline, combined with prior disclosure that funds were not being deployed into new receivables, is consistent with book run-off rather than a trading setback.
• The narrower loss is not a recovery signal. PBT improved by NZ$126.1m, but on a sharply smaller revenue base and against a backdrop of negative equity. Loss narrowing here reflects a smaller book rather than operational leverage.

Expectations

No quantitative targets, guidance, or forward-work backlog were disclosed. Shape context from FY21 shows HY21 accounted for 68.6% of full-year revenue and 79.9% of the full-year loss, with the implied H2 FY21 operating cash flow sharply negative (–NZ$274.2m) as the book began running down. Annualising HY22 revenue gives NZ$67.5m, roughly half FY21's NZ$135.4m, pointing to continued top-line decay rather than stabilisation. No dividend is proposed, consistent with the prior year.

Quality of result

Low durability. The positive operating cash flow of NZ$331.3m looks balance-sheet-assisted: it is consistent with receivable collections on a run-off book rather than earnings-driven cash generation, and it fell 27.4% even as the loss narrowed. Free cash flow equals operating cash flow because capex is nil, but FCF as a percentage of NPAT is a non-meaningful –153.5% given the loss. Cash conversion deterioration is flagged directly by the calculation pass. With revenue dependent on an interest-earning asset pool that is contracting and negative equity on the balance sheet, very little of the result reads as recurring.

Unresolved

• What is the composition and credit quality of the remaining NZ$1.48bn asset base, and how does it reconcile to the NZ$1.44bn of remaining borrowings given negative equity?
• Who are the lenders behind the NZ$1.44bn of borrowings, what are the covenants, and on what timeline must they be repaid as the book runs off?
• What does the proposed reverse takeover actually involve — target industry, size, consideration, dilution — and how will existing borrowings be treated through that transaction?
• Is there any impairment catch-up still to come, or has the loss absorption largely been taken?

This briefing cannot assess solvency, covenant headroom, or the economics of the proposed RTO because none of those items were disclosed in the supplied extracts.

Key metrics

Analytical metrics

This analysis was generated using Annolyse, an AI-powered tool that analyses NZX company announcements. The analysis is based on available company filings and standard Annolyse calculations. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.